Steven LaRosa
Corporate Officer/Principal bei AETHLON MEDICAL, INC.
Vermögen: - $ am 30.04.2024
Profil
Steven P.
LaRosa is currently the Chief Medical Officer at Aethlon Medical, Inc. and a Member at Beth Israel Lahey Health, Inc. He previously worked as the Medical Director-Antimicrobial Stewardship Program at Northeast Hospital Corp.
and as the Vice President-Clinical Development at Entasis Therapeutics, Inc. for a brief period in 2020.
LaRosa completed his undergraduate degree at Boston College and his doctorate at Boston University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AETHLON MEDICAL, INC.
-.--% | 30.06.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Steven LaRosa
| Unternehmen | Position | Beginn |
|---|---|---|
| AETHLON MEDICAL, INC. | Corporate Officer/Principal | 06.01.2021 |
Beth Israel Lahey Health, Inc.
 Beth Israel Lahey Health, Inc. Medical/Nursing ServicesHealth Services Beth Israel Lahey Health, Inc. is a non-profir organization provides healthcare services. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Steven LaRosa
| Unternehmen | Position | Ende |
|---|---|---|
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.12.2020 |
| Northeast Hospital Corp. | Corporate Officer/Principal | - |
Ausbildung von Steven LaRosa
| Boston University School of Medicine | Doctorate Degree |
| Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AETHLON MEDICAL, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Health Technology |
| Northeast Hospital Corp. | |
Beth Israel Lahey Health, Inc.
Beth Israel Lahey Health, Inc. Medical/Nursing ServicesHealth Services Beth Israel Lahey Health, Inc. is a non-profir organization provides healthcare services. The company is headquartered in Cambridge, MA. | Health Services |
